Combined behavioral therapy and pharmacotherapy of agoraphobia.
There are few controlled studies of combined behavioral-pharmacological treatments of agoraphobia with panic. This review of the empirical evidence from studies using exposure in vivo as the behavioral modality and imipramine as the pharmacological agent suggests that these treatments have mutually potentiating effects in this disorder.
Mavissakalian
M
M
Department of Psychiatry, Ohio State University, College of Medicine, Columbus 43210-1228.
D000379:Agoraphobia / Q000523:psychology / Q000628:therapy*; D001521:Behavior Therapy; D003131:Combined Modality Therapy; D003887:Desensitization, Psychologic; D005500:Follow-Up Studies; D006801:Humans; D007099:Imipramine / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D007099:Imipramine